Pacientes Colombia cuestiona destino de recursos de salud ante fallas en entrega de medicamentos de Nueva EPS

TL;DR

Pacientes Colombia is questioning the destination of funds received by Nueva EPS, highlighting the impact on affiliated patients.
Colsubsidio and Medicarte ceased providing services to Nueva EPS on January 1, 2026, due to pending debts or contract terminations.
Patients have reported operational failures, unactivated dispensing points, and uncertainty about treatment continuity since January 4.
Pharmaceutical managers report over $852,000 million in accumulated debts within the sector.
Nueva EPS receives approximately $16 trillion annually from the contributory and subsidized regimes.
Denis Silva of Pacientes Colombia questions the use of funds, asking why payments to providers and medication managers are not guaranteed.
Over 11.5 million affiliates nationwide are affected, facing choices between food and medication.
Reports indicate Nueva EPS owes $21.3 trillion to hospitals and providers, has $15.2 trillion in unlegalized advances, and a negative equity of $4.4 trillion.
Pacientes Colombia suggests administrative mismanagement or opacity in resource use.
The organization demands immediate explanations from Nueva EPS and information from the National Health Superintendence.
The Attorney General's Office previously certified Nueva EPS's loss of capacity to guarantee the right to health, with over 500 avoidable deaths in 2025 linked to access barriers.

Continuar leyendo el artículo original